Annual ROA
-11.94%
+19.53%+62.06%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual return on assets is currently -11.94%, with the most recent change of +19.53% (+62.06%) on 31 December 2023. During the last 3 years, it has risen by +17.64% (+59.63%). ALNY annual ROA is now -138.32% below its all-time high of -5.01%, reached on 31 December 2008.ALNY ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-8.43%
-6.50%-336.79%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly return on assets is currently -8.43%, with the most recent change of -6.50% (-336.79%) on 30 September 2024. Over the past year, it has increased by +5.96% (+41.42%). ALNY quarterly ROA is now -336.79% below its all-time high of -1.93%, reached on 30 June 2024.ALNY Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.1% | +41.4% |
| 3 y3 years | +59.6% | +65.9% |
| 5 y5 years | +72.0% | +78.4% |
ALNY ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +62.1% | -336.8% | +75.2% |
| 5 y | 5 years | at high | +73.3% | -336.8% | +78.6% |
| alltime | all time | -138.3% | +83.2% | -336.8% | +89.3% |
Alnylam Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -8.43%(+336.8%) |
| June 2024 | - | -1.93%(-78.7%) |
| Mar 2024 | - | -9.08%(-25.7%) |
| Dec 2023 | -11.94%(-62.1%) | -12.22%(-15.1%) |
| Sept 2023 | - | -14.39%(-53.4%) |
| June 2023 | - | -30.91%(+0.1%) |
| Mar 2023 | - | -30.89%(-4.5%) |
| Dec 2022 | -31.47%(+30.1%) | -32.34%(-4.7%) |
| Sept 2022 | - | -33.94%(+20.4%) |
| June 2022 | - | -28.20%(+9.4%) |
| Mar 2022 | - | -25.78%(+4.5%) |
| Dec 2021 | -24.19%(-18.2%) | -24.67%(-0.2%) |
| Sept 2021 | - | -24.72%(-6.0%) |
| June 2021 | - | -26.31%(-6.2%) |
| Mar 2021 | - | -28.05%(-3.5%) |
| Dec 2020 | -29.58%(-33.7%) | -29.07%(-9.3%) |
| Sept 2020 | - | -32.05%(+0.8%) |
| June 2020 | - | -31.79%(-14.3%) |
| Mar 2020 | - | -37.10%(-5.9%) |
| Dec 2019 | -44.64%(+4.6%) | -39.41%(+1.0%) |
| Sept 2019 | - | -39.03%(-11.1%) |
| June 2019 | - | -43.91%(-1.7%) |
| Mar 2019 | - | -44.68%(+5.1%) |
| Dec 2018 | -42.67%(+41.6%) | -42.51%(+7.3%) |
| Sept 2018 | - | -39.60%(+18.1%) |
| June 2018 | - | -33.53%(+0.2%) |
| Mar 2018 | - | -33.45%(-2.1%) |
| Dec 2017 | -30.14%(-2.6%) | -34.16%(-3.7%) |
| Sept 2017 | - | -35.49%(+4.6%) |
| June 2017 | - | -33.92%(+4.9%) |
| Mar 2017 | - | -32.33%(+5.0%) |
| Dec 2016 | -30.96%(+31.6%) | -30.78%(+8.5%) |
| Sept 2016 | - | -28.38%(+11.0%) |
| June 2016 | - | -25.57%(+9.0%) |
| Mar 2016 | - | -23.45%(+14.2%) |
| Dec 2015 | -23.52%(-51.1%) | -20.54%(+24.0%) |
| Sept 2015 | - | -16.57%(+10.3%) |
| June 2015 | - | -15.02%(+8.9%) |
| Mar 2015 | - | -13.79%(-64.8%) |
| Dec 2014 | -48.05% | -39.18%(-16.3%) |
| Sept 2014 | - | -46.80%(-9.7%) |
| June 2014 | - | -51.84%(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -57.44%(+169.0%) |
| Dec 2013 | -25.20%(-32.3%) | -21.35%(-28.6%) |
| Sept 2013 | - | -29.89%(+2.3%) |
| June 2013 | - | -29.23%(-1.8%) |
| Mar 2013 | - | -29.78%(-12.9%) |
| Dec 2012 | -37.23%(+118.0%) | -34.19%(+85.1%) |
| Sept 2012 | - | -18.47%(+13.4%) |
| June 2012 | - | -16.29%(+1.5%) |
| Mar 2012 | - | -16.05%(-5.6%) |
| Dec 2011 | -17.08%(+71.7%) | -17.00%(+23.5%) |
| Sept 2011 | - | -13.77%(+15.4%) |
| June 2011 | - | -11.93%(+4.5%) |
| Mar 2011 | - | -11.42%(+15.0%) |
| Dec 2010 | -9.95%(+8.3%) | -9.93%(+2.6%) |
| Sept 2010 | - | -9.68%(+5.7%) |
| June 2010 | - | -9.16%(-11.5%) |
| Mar 2010 | - | -10.35%(+13.4%) |
| Dec 2009 | -9.19%(+83.4%) | -9.13%(+0.3%) |
| Sept 2009 | - | -9.10%(+18.5%) |
| June 2009 | - | -7.68%(+28.6%) |
| Mar 2009 | - | -5.97%(+22.6%) |
| Dec 2008 | -5.01%(-78.5%) | -4.87%(+69.7%) |
| Sept 2008 | - | -2.87%(-79.9%) |
| June 2008 | - | -14.25%(-15.4%) |
| Mar 2008 | - | -16.84%(-33.6%) |
| Dec 2007 | -23.29%(+13.8%) | -25.35%(-29.1%) |
| Sept 2007 | - | -35.75%(+39.5%) |
| June 2007 | - | -25.63%(-1.3%) |
| Mar 2007 | - | -25.96%(+17.6%) |
| Dec 2006 | -20.46%(-60.8%) | -22.08%(-36.3%) |
| Sept 2006 | - | -34.64%(-22.2%) |
| June 2006 | - | -44.54%(-20.1%) |
| Mar 2006 | - | -55.74%(-17.5%) |
| Dec 2005 | -52.19%(-19.1%) | -67.55%(+11.6%) |
| Sept 2005 | - | -60.54%(+24.5%) |
| June 2005 | - | -48.63%(+12.0%) |
| Mar 2005 | - | -43.43%(-27.7%) |
| Dec 2004 | -64.48%(-9.4%) | -60.10%(-7.0%) |
| Sept 2004 | - | -64.63%(-6.8%) |
| June 2004 | - | -69.35%(-11.9%) |
| Mar 2004 | - | -78.75%(+54.7%) |
| Dec 2003 | -71.15%(+177.2%) | -50.91% |
| Dec 2002 | -25.67% | - |
FAQ
- What is Alnylam Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual ROA year-on-year change?
- What is Alnylam Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly ROA year-on-year change?
What is Alnylam Pharmaceuticals annual return on assets?
The current annual ROA of ALNY is -11.94%
What is the all time high annual ROA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual return on assets is -5.01%
What is Alnylam Pharmaceuticals annual ROA year-on-year change?
Over the past year, ALNY annual return on assets has changed by +19.53% (+62.06%)
What is Alnylam Pharmaceuticals quarterly return on assets?
The current quarterly ROA of ALNY is -8.43%
What is the all time high quarterly ROA for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly return on assets is -1.93%
What is Alnylam Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, ALNY quarterly return on assets has changed by +5.96% (+41.42%)